US needs to invest more in new technology for diabetes care
This article was originally published in Clinica
The US allocated $1.32bn to medical expenditure and lost productivity in 2001 compared, to $98bn in 1997, according to a new study by the American Diabetes Association (ADA). The direct medical costs of diabetes more than doubled during the same period, from $44bn in 1997 to $91.8bn in 2002, the group said. Greater preparedness to use new technologies would result in lower healthcare costs and better productivity, believes the ADA.